Del. Jury Finds Kurin Infringed Rival's Blood-Testing Patent

By Dorothy Atkins · July 26, 2022, 9:16 PM EDT

A Delaware federal jury found Tuesday that Kurin Inc.'s blood-testing products infringe Magnolia Medical Technologies Inc.'s blood-testing patent in the first phase of the two-part jury trial, sending the case to...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Magnolia Medical Technologies, Inc. v. Kurin, Inc.

Case Number

1:19-cv-00097

Court

Delaware

Nature of Suit

Patent

Date Filed

January 16, 2019